Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
about
Management of antipsychotic-related weight gainCurrent Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewDoes tobacco use cause psychosis? Systematic review and meta-analysisA comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK populationAppraising evidence for intervention effectiveness in early psychosis: conceptual framework and review of evaluation approaches.The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.Antipsychotic drugs and obesity.Almost all antipsychotics result in weight gain: a meta-analysis.Association of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study).Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease.Addressing cardiometabolic risk during treatment with antipsychotic medications.Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complicationsSchizophrenia, obesity, and antipsychotic medications: what can we do?Weight gain associated with taking psychotropic medication: an integrative review.Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.Atypical antipsychotic-induced weight gain: insights into mechanisms of action.Beyond pharmacotherapy: understanding the links between obesity and chronic mental illness.Weight changes and characteristics of patients associated with weight gain during inpatient psychiatric treatment.Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review.Weight considerations in psychotropic drug prescribing and switching.Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics.Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications.Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.Changes in BMI in hospitalized patients during treatment with antipsychotics, depending on gender and other factors.Body composition, pre-diabetes and cardiovascular disease risk in early schizophrenia.Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis.Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study.Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study.No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample.Trend in rates for deaths with mention of schizophrenia on death certificates of US residents, 1999-2010.Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.Evolving role of mental health nurses in the physical health care of people with serious mental health illness.
P2860
Q24610124-51A363CE-2402-4B37-AFAF-56F2701B23EDQ28079821-298AC43E-56F2-43C6-B08A-1F3E8ED8BCC2Q30694281-66F67CFE-32FA-475A-B3F5-49D89E864FADQ31010040-1BF10D61-76A0-4E5C-862A-DCD2C68A13B8Q33533853-ADEE1B85-4D55-4F53-9B49-824ADC9BE5BAQ34418847-2F08237B-0EE5-4BB1-BD9D-5FB364F5CCB6Q34641561-E964CCC6-3EC7-4C0E-87BA-2A0CC6173226Q34648940-3ECB234D-22D9-482D-85EB-E747C125FC8DQ34661499-0FA6FABC-C556-4CF8-99F9-65304EAB2F3CQ35460642-EFF7ADBA-478A-4364-8748-B239F205E43AQ37110540-C7D4E46D-AA66-4DB5-BCEA-6464D55F2D06Q37183591-9CD007BC-CF4F-4743-984D-EAA993D0A74AQ37220366-F96E4C4E-09D7-418E-A285-747D36C114CBQ37226376-D9E8DD18-0846-416F-B6BD-282C22885371Q37865068-85116D9B-FE90-481B-AD94-3181D83E7F11Q37947095-3F6F8F38-A5F0-482F-B9CD-BE66E1EC53FDQ37963571-4CE1DC15-30A7-4AA4-B3C7-3F89C5D27B4BQ37980570-9462A3E9-3BBF-48F5-B98B-79639B0DD650Q38031006-1EE812B1-7340-4902-94F8-F15FB2C82C19Q38064842-A78C2766-E5D2-4E32-AACC-183B55641900Q38151453-4794C86D-76BB-4E5C-B83B-86DCE55EB409Q38154174-2E66CA40-8459-4766-81F0-D673AA1B6FB2Q38473090-D35293F4-F4F7-40FB-A820-1FFB8FFF64B8Q38504254-27EC6FBA-7B80-455D-82D3-16EF3FDDB5EBQ38789687-D9180799-10F7-4A4D-8480-3A5275995EB2Q41266276-FDC879C0-FE71-4626-BA89-E3A67EDD4F40Q43294341-6CFEE9A5-3E00-4049-AB03-A28917C0370FQ43613438-1B90D7E9-4D55-4332-A98A-4A2649D69208Q45369679-0D858FC4-F790-4172-B782-A944DA807C62Q45928108-D30B141B-80AD-4140-AE39-BEA6F388DA1EQ46195221-A4EE517F-83DB-46E1-ACFD-7FE4EA11C6AAQ46534644-77CE5479-17DF-4D48-9BA7-D2944032F644Q48243224-7FB24D5E-FB18-42DE-90B7-7F26BB537A32Q50760224-90DDABC2-11ED-417B-A532-EA3B525E54A1
P2860
Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Weight gain in newly diagnosed ...... omparisons: one-year analysis.
@en
type
label
Weight gain in newly diagnosed ...... omparisons: one-year analysis.
@en
prefLabel
Weight gain in newly diagnosed ...... omparisons: one-year analysis.
@en
P2093
P2860
P1476
Weight gain in newly diagnosed ...... omparisons: one-year analysis.
@en
P2093
Jean Miewald
Martin Strassnig
Matcheri Keshavan
Rohan Ganguli
P2860
P356
10.1016/J.SCHRES.2007.02.024
P407
P577
2007-05-02T00:00:00Z